Top 5 Fast-growings companies in Ribociclib by Most Patent Filing In 5 Years in the United States in 2022 – Discovery

Free Trial

The Ribociclib top 5 is Discovery PatSnap’ annual ranking of the top 5 Most Patent Filing In 5 Years Ribociclib Fast-growings in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

Ranking Year:

Region:

Ranking:

1	University of Tennessee Research Foundation	Tennessee, United States		Patent: 4
2	Olema Pharmaceuticals, Inc.	California, United States	Biopharmaceutical,Health care,Estrogen receptor, ...[+2]	Patent: 4
3	Teva Pharmaceuticals USA, Inc.	Pennsylvania, United States	Trade partner,Corporate social responsibility,Medicine, ...[+2]	Patent: 2
4	Board of Regents of The University of Oklahoma	Oklahoma, United States	Radio broadcasting station,Radio broadcasting,Broadcasting	Patent: 2
5	Olaris, Inc.	Massachusetts, United States	Substance abuse,Health care,Biotechnology, ...[+2]	Patent: 1